|
|
Article: FDA Approves Once-Daily Veramyst(TM) (fluticasone furoate) Nasal Spray for Treatment of Seasonal and Year-Round Allergy Symptoms in Adults and Children as Young as Two Years
- Article from:
- U.S. Newswire
- Article date:
- April 30, 2007
CopyrightCopyright 2007 U.S. Newswire. Provided by ProQuest LLC. (Hide copyright information)
|
To: MEDICAL EDITORS
Contact: US Media inquiries, Holly Russell, 919-483-2839, or Mary
Anne Rhyne, 919-483-2839; or UK Media inquiries, Phil Thomson (020)
8047 5502, Joss Mathieson,(020) 8047 5502, or Gwenan White, (020)
8047 5502; or US Analyst-Investor inquiries, Frank Murdolo, 215-751-
7002, or Tom Curry 215-751-5419; or European Analyst-Investor
inquiries, Anita Kidgell,(020) 8047 5542, David Mawdsley, (020) 8047
5564, or Sally Ferguson, (020) 8047 5543
RESEARCH TRIANGLE PARK, N.C., April 30 /PRNewswire/ -- The U.S.
Food and Drug Administration approved once-daily Veramyst(TM)
(fluticasone furoate) Nasal Spray on Friday to treat seasonal and
year-round allergy symptoms in adults and ...